Key result
Multimodal assessment accurately stratifies CV risk and guides preventive therapies in intermediate-risk patients.
Case Report (n=1)
This case highlights the limitations of independent cardiovascular risk stratification tools and reinforces the need for multimodal assessment strategies for preventive therapies.
Should not yet change practice; leaves open whether multimodal assessment improves risk stratification in intermediate-risk patients.
BACKGROUND: Cardiovascular risk stratification is essential and informative for long-term prognostication. However, it is often limited by heterogeneous patient profiles. CASE SUMMARY: An asymptomatic 76-year-old man with a history of multiple myeloma in remission presented for cardiovascular risk assessment. Despite intermediate-risk classification of atherosclerotic cardiovascular disease using risk stratification scores, the coronary artery calcium score (73 Agatston units) was used to guide decision-making regarding initiation of lipid-lowering therapy. However, before therapy initiation, the patient experienced an ST-segment elevation myocardial infarction. DISCUSSION: Cardiovascular risk stratification tools serve an important role in evaluating patient risk and facilitating shared decision-making in clinical management. Nonetheless, these tools present certain limitations in predicting comprehensive risk outcomes, especially when used independently. KEY TAKEAWAYS: This case highlights the intricacies associated with cardiovascular risk stratification tools and reinforces the importance of using a multimodal assessment strategy to inform the initiation of preventive therapies.
No takes yet. Share an insight, caveat, or question.
Akinmolayemi et al. (2026) conducted a case report in Acute Myocardial Infarction (n=1). Cardiovascular risk stratification tools was evaluated on ST-segment elevation myocardial infarction. A 76-year-old man classified as intermediate-risk by cardiovascular risk stratification scores experienced an ST-segment elevation myocardial infarction before initiating lipid-lowering therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: